Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways
Julie Langlois(Roche (Switzerland)), James Keaney(UCB Pharma (Belgium))
Cited by 18
Related Papers
No related papers found
Powered by citation graph analysis